Home Tags Stem cells

Tag: Stem cells

Lineage Cell Therapeutics Issued US Patent For Antigen Presenting Dendritic Cell Production System

Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, has announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 10,344,262, for a system for production of antigen presenting dendritic cells...

Americord Registry Launches Amniotic Membrane Biobanking, New Product

Americord Registry has launched its newest stem cell banking product, Placental Tissue 2.0™. Americord was one of the first family cord blood banks to store placental tissue and now offers this exciting product, which stores live amniotic membrane (AM), a first for...

Be The Match® And Gift Of Life® Marrow Registry To Open Blood Stem Cell...

Be The Match® and Gift of Life® Marrow Registry, intend to open, in late July, the first registry-operated blood stem cell collection facility in Boca Raton, Florida. The Gift of Life - Be The Match Collection Center brings to life a new...

TreeFrog Therapeutics Raises $7.8M To Develop C-Stem™ 3D Stem Cell Culture In Multiple Indications

TreeFrog Therapeutics, an expert stem cell company, has raised €7.1M (USD $7.8M) in a Series A funding round. The proceeds will be used to transition the company’s C-Stem™ technology to cGMP standards by 2021 and to develop proprietary and collaborative cell therapy...

FDA Grants RMAT To ExCellThera’s Cell Expansion Technology

ExCellThera Inc., an advanced clinical stage biotechnology company delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use, has announced that the U.S. Food and Drug Administration (FDA) has granted regenerative medicine advanced therapy (RMAT) designation to its lead...

BrainStorm Cell Therapeutics Contracts Cleveland Clinic For Multiple Sclerosis Clinical Trial Site

BrainStorm Cell Therapeutics Inc., has announced that the Cleveland Clinic is the first U.S. clinical site contracted for a planned Phase 2 open-label, multicenter study of repeated intrathecal administration of autologous mesenchymal stem cells secreting neurotrophic factors (MSC-NTF) in...

Houston Stem Cells Clinic Inc Opened By China Infrastructure Construction Corp

China Infrastructure Construction Corp., (CHNC) has announced that it has opened Houston Stem Cells Clinic Inc., as a wholly owned subsidiary of CHNC. According to Reuters, CHNC has an office in Wheat Ridge, Colorado, USA. Houston Stem Cell Clinic Inc....

Cellect Prepared For US Clinical Trial

Cellect Biotechnology Ltd. has announced a collaboration with Washington University in St. Louis, Missouri, USA, in a U.S. Phase I/II study aimed at determining the safety and tolerability of using ApoGraft™ for bone marrow transplantations. Founded in 2011, located in...

Cellect Biotechnology Completes Scale-Up Of Clinical Grade FasL; Enabling Stem Cell Therapy

Cellect Biotechnology Ltd. has announced that it has concluded the scale-up development and manufacturing of clinical grade FasL in collaboration with its outsourced supplier. Founded in 2011, located in Tel Aviv, Isreal, Cellect Biotechnology has developed a breakthrough technology for...

StemCyte Receives IND Clearance Of Mononuclear Stem Cells In Spinal Cord Injury Clinical Trials

On December 14, 2018, the U.S. Food and Drug Administration (FDA), approved StemCyte’s Phase II Investigational New Drug (IND) application for Allogeneic Human Leukocyte Antigen (HLA)-Matched Umbilical Cord Blood Mononuclear Stem Cells (UCBMNC) (MC001) for the treatment of spinal cord injury. Founded in 1997,...

⭐ Recently Featured

🔥 Popular Posts

X